Windlas Biotech Ltd.

NSE: WINDLAS BSE: 543329 SECTOR: Pharmaceuticals & Drugs  10k   37   12

327.10
-5.85 (-1.76%)
NSE: 22 Oct 03:59 PM

Price Summary

Today's High

₹ 338

Today's Low

₹ 326

52 Week High

₹ 452

52 Week Low

₹ 332.05

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

712.89 Cr.

Enterprise Value

713.25 Cr.

No. of Shares

2.18 Cr.

P/E

142.29

P/B

1.17

Face Value

₹ 5

Div. Yield

0 %

Book Value (TTM)

₹  278.67

CASH

30.96 Cr.

DEBT

31.32 Cr.

Promoter Holding

-

EPS (TTM)

₹  2.3

Sales Growth

30.03%

ROE

2.39 %

ROCE

5.22%

Profit Growth

-78.84 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year30.03%
3 Year10.11%
5 Year9.35%

Profit Growth

1 Year-78.84%
3 Year-33.33%
5 Year1.95%

ROE%

1 Year2.39%
3 Year8.23%
5 Year11.01%

ROCE %

1 Year5.22%
3 Year11.43%
5 Year13.33%

Debt/Equity

0.1574

Price to Cash Flow

62.27

Interest Cover Ratio

9.66666666666667

CFO/PAT (5 Yr. Avg.)

1.35199362970732

Share Holding Pattern

Investors List Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • Company has a healthy Interest coverage ratio of 9.66666666666667.
  • The company has an efficient Cash Conversion Cycle of 38.865182202161 days.
  • Company has a healthy liquidity position with current ratio of 2.07824960661107.
  • The company has a good cash flow management; CFO/PAT stands at 1.35199362970732.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 10.5635489997026.

 Limitations

  • The company has shown a poor profit growth of -33.3282727259687% for the Past 3 years.
  • The company has shown a poor revenue growth of 10.1083550818074% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2021
Net Sales 110.96
Total Expenditure 98.57
Operating Profit 12.39
Other Income 0.69
Interest 0.48
Depreciation 3.03
Exceptional Items 0
Profit Before Tax 9.57
Tax 2.88
Profit After Tax 6.69
Adjusted EPS (Rs) 3.67

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 315.16 320.32 288.2 328.85 427.6
Total Expenditure 290.35 281.92 243.74 287.39 372.91
Operating Profit 24.81 38.39 44.47 41.47 54.69
Other Income 3.74 2.8 2.12 2.49 3.09
Interest 4.99 4.74 3.64 2.53 1.29
Depreciation 9.46 11.32 8.09 9.29 12.97
Exceptional Items 0 0 0 0 -32.35
Profit Before Tax 14.11 25.13 34.86 32.13 11.18
Tax 4.94 8.23 12.39 8.46 6.17
Net Profit 9.17 16.9 22.47 23.68 5.01
Adjusted EPS (Rs.) 16.4 30.25 35.05 36.94 7.81

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 8.53 8.53 6.41 6.41 6.41
Total Reserves 141.3 158.2 187.61 213.94 192.58
Borrowings 18.19 11.54 5.82 1.21 0.83
Other N/C liabilities 0.37 -0.76 -0.78 1.66 2.75
Current liabilities 134.87 119.68 96.12 125.29 93.42
Total Liabilities 303.26 297.19 295.17 348.52 295.99
Assets
Net Block 56.2 58.22 61.93 70.26 95.94
Capital WIP 15.14 10.51 4.58 0 0.04
Intangible WIP 0 0 0 0 0
Investments 91.18 104.69 104.69 104.69 0.03
Loans & Advances 5.83 6.14 7.6 5.4 5.84
Other N/C Assets 0.1 0 0 0.13 0
Current Assets 134.81 117.63 116.38 168.03 194.15
Total Assets 303.26 297.19 295.17 348.52 295.99
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 14.11 25.13 34.86 32.13 11.18
Adjustment 12.02 14.97 9.87 9.77 46.85
Changes in Assets & Liabilities -17.61 4.34 -9.28 -3.53 -40.05
Tax Paid -1.59 -5.39 -13.37 -13.46 -6.53
Operating Cash Flow 6.94 39.05 22.08 24.91 11.45
Investing Cash Flow -38.77 -10.82 -6.59 -14.25 -14.53
Financing Cash Flow 4.92 -24.58 -7.85 -5.44 0.78
Net Cash Flow -26.92 3.65 7.64 5.22 -2.3

Corporate Actions

Investors Details

Investors Details is not available for this company.
Report us

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

Company Presentations

Windlas Biotech Stock Price Analysis and Quick Research Report. Is Windlas Biotech an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Windlas Biotech and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 11.448 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Windlas Biotech has a Debt to Equity ratio of 0.1574 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Windlas Biotech , the EPS growth was -78.8420119092867 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Windlas Biotech has OPM of 12.7903985481827 % which is a bad sign for profitability.
     
  • ROE: Windlas Biotech have a poor ROE of 2.38947486401217 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Windlas Biotech

X